Stay updated on PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page.

Latest updates to the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page shows a revision from v3.2.0 to v3.3.2; no changes to core study details, eligibility criteria, outcomes, or locations were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedA government funding status banner was removed from the page; no trial details, eligibility criteria, or study results were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedTwo screenshots depict the same ClinicalTrials.gov study page with no substantive updates to core content such as eligibility criteria, endpoints, or study purpose; observed differences appear to be formatting/layout variations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedMajor update: adds a government funding/operating status notice and updates version to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check78 days agoChange DetectedUpdated revision to v3.1.0 and added new contact extensions; removed old revision v3.0.2.SummaryDifference0.0%

- Check92 days agoChange DetectedUpdated to v3.0.2 (replacing v3.0.1); the Back to Top element was removed as a minor UI change.SummaryDifference0.1%

Stay in the know with updates to PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page.